| Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy (NCT05154474) | Weprom | 2022-06-01 |
| Intermittent Fasting and CLL/SLL (NCT04626843) | Eleah Stringer | 2021-02-03 |
| Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (NCT04030195) | Precision BioSciences, Inc. | 2020-03-24 |
| Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT03204188) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-09-22 |
| Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL (NCT02758665) | University of Ulm | 2016-09-01 |
| A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors (NCT02440685) | Asana BioSciences | 2015-05-01 |
| MSC and HSC Coinfusion in Mismatched Minitransplants (NCT01045382) | University of Liege | 2010-07-01 |
| Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit (NCT01050946) | Medical College of Wisconsin | 2009-07-01 |
| EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00636155) | David Rizzieri | 2008-02-01 |
| Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL (NCT00546793) | Gilead Sciences | 2008-01-01 |
| Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients (NCT00562224) | Pharmacyclics LLC. | 2007-11-01 |
| Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL) (NCT00464633) | Sanofi | 2007-03-01 |
| Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor (NCT00393380) | The Emmes Company, LLC | 2006-09-01 |
| Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL) (NCT00290407) | University of Louisville | 2006-03-01 |
| Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL) (NCT00289549) | BioCryst Pharmaceuticals | 2005-06-01 |
| Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies (NCT00131014) | Dana-Farber Cancer Institute | 2004-08-09 |
| A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia (NCT00083473) | Titan Pharmaceuticals | 2004-05-01 |
| Post Transplant Donor Lymphocyte Infusion (NCT00167180) | Masonic Cancer Center, University of Minnesota | 2004-01-01 |
| Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) (NCT00055146) | Eisai Inc. | 2003-03-01 |
| A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach (NCT00038415) | M.D. Anderson Cancer Center | 2001-12-01 |
| Stem Cell Transplant for Hematological Malignancy (NCT00176930) | Masonic Cancer Center, University of Minnesota | 2001-10-01 |
| Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies (NCT00038883) | M.D. Anderson Cancer Center | 2001-04-09 |
| Clofarabine in Chronic Lymphocytic Leukemia (NCT00028418) | M.D. Anderson Cancer Center | 1999-02-01 |
| Phase III Study Treatment of CLL B and C (NCT00535912) | French Innovative Leukemia Organisation | 1999-01-01 |
| Transplantation for Patients With Chronic Lymphocytic Leukemia (NCT00186303) | Stanford University | 1996-11-01 |
| Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia (NCT00270049) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1990-11-01 |
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) (NCT00076401) | Pharmacyclics LLC. | |